Gestion des effets secondaires des thérapies ciblées dans le cancer du rein: Thérapies ciblées et effets secondaires dermatologiques

Caroline Robert; Pierre Gimel

doi:10.1684/bdc.2011.1448

Gestion des effets secondaires des thérapies ciblées dans le cancer du rein: Thérapies ciblées et effets secondaires dermatologiques

Caroline Robert, Pierre Gimel

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

2 Citations (Scopus)

Résumé

Targeted therapies used (angiogenesis inhibitors and mTOR inhibitors) in advanced renal cell carcinoma have a constellation of reaction affecting the skin, hair and nails. This guideline describes the incidence, clinical presentation and treatment of dermatologic side effects that develop with the use of targeted therapies (sunitinib, sorafenib, pazopanib, bevacizumab, everolimus, temsirolimus).

Titre traduit de la contribution	Management of side effects of targeted therapies in renal cancer: Cutaneous side effects
langue originale	Français
Pages (de - à)	S35-S46
journal	Bulletin du Cancer
Volume	98
Numéro de publication	SUPPL. 3
Les DOIs	https://doi.org/10.1684/bdc.2011.1448
état	Publié - 1 janv. 2011

mots-clés

Alopecia
Hand-foot syndrome
Rash

Accès au document

10.1684/bdc.2011.1448

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{4810307f4dfb46388757daed44117b19,

title = "Gestion des effets secondaires des th{\'e}rapies cibl{\'e}es dans le cancer du rein: Th{\'e}rapies cibl{\'e}es et effets secondaires dermatologiques",

abstract = "Targeted therapies used (angiogenesis inhibitors and mTOR inhibitors) in advanced renal cell carcinoma have a constellation of reaction affecting the skin, hair and nails. This guideline describes the incidence, clinical presentation and treatment of dermatologic side effects that develop with the use of targeted therapies (sunitinib, sorafenib, pazopanib, bevacizumab, everolimus, temsirolimus).",

keywords = "Alopecia, Hand-foot syndrome, Rash",

author = "Caroline Robert and Pierre Gimel",

year = "2011",

month = jan,

day = "1",

doi = "10.1684/bdc.2011.1448",

language = "Fran{\c c}ais",

volume = "98",

pages = "S35--S46",

journal = "Bulletin du Cancer",

issn = "0007-4551",

number = "SUPPL. 3",

}

TY - JOUR

T1 - Gestion des effets secondaires des thérapies ciblées dans le cancer du rein

T2 - Thérapies ciblées et effets secondaires dermatologiques

AU - Robert, Caroline

AU - Gimel, Pierre

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Targeted therapies used (angiogenesis inhibitors and mTOR inhibitors) in advanced renal cell carcinoma have a constellation of reaction affecting the skin, hair and nails. This guideline describes the incidence, clinical presentation and treatment of dermatologic side effects that develop with the use of targeted therapies (sunitinib, sorafenib, pazopanib, bevacizumab, everolimus, temsirolimus).

AB - Targeted therapies used (angiogenesis inhibitors and mTOR inhibitors) in advanced renal cell carcinoma have a constellation of reaction affecting the skin, hair and nails. This guideline describes the incidence, clinical presentation and treatment of dermatologic side effects that develop with the use of targeted therapies (sunitinib, sorafenib, pazopanib, bevacizumab, everolimus, temsirolimus).

KW - Alopecia

KW - Hand-foot syndrome

KW - Rash

UR - http://www.scopus.com/inward/record.url?scp=84855679846&partnerID=8YFLogxK

U2 - 10.1684/bdc.2011.1448

DO - 10.1684/bdc.2011.1448

M3 - Article

AN - SCOPUS:84855679846

SN - 0007-4551

VL - 98

SP - S35-S46

JO - Bulletin du Cancer

JF - Bulletin du Cancer

IS - SUPPL. 3

ER -